Skip navigation
Skip navigation

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study

Robman, Liubov; Guymer, Robyn; Woods, Robyn; Ward, Stephanie; Wolfe, Rory; Phung, James; Hodgson, Lauren; Makeyeva, Galina; Aung, Khin Zaw; Gilbert, Tom; Abhayaratna, Walter


Although aspirin therapy is used widely in older adults for prevention of cardiovascular disease, its impact on the incidence, progression and severity of age-related macular degeneration (AMD) is uncertain. The effect of low-dose aspirin on the course of AMD will be evaluated in this clinical trial. A sub-study of the ‘ASPirin in Reducing Events in the Elderly’ (ASPREE) trial, ASPREE-AMD is a 5-year follow-up double-blind, placebo-controlled, randomized trial of the effect of 100 mg daily...[Show more]

CollectionsANU Research Publications
Date published: 2017
Type: Journal article
Source: Contemporary Clinical Trials Communications
DOI: 10.1016/j.conctc.2017.03.005
Access Rights: Open Access


File Description SizeFormat Image
01_Robman_Age-related_macular_2017.pdf336.26 kBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator